Related Experiment Videos

Radical TUR and chemotherapy aiming at bladder preservation

R R Hall¹, J T Roberts, M M Marsh

¹Department of Urology, Freeman Hospital, Newcastle upon Tyne, UK.

Progress in Clinical and Biological Research

|January 1, 1990

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Metachronous testicular teratoma, testicular seminoma and papillary thyroid carcinoma occurring in a single individual: a report of two unrelated cases.

European journal of cancer care·2009

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2006

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.

European journal of cancer (Oxford, England : 1990)·2005

Chemotherapy for metastatic bladder cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2005

Modelling the expected increase in demand for particle radiotherapy: implications for the UK.

The British journal of radiology·2005

See all related articles